Related Experiment Video
Updated: Aug 8, 2026
Generation of Human CD40-activated B cells
Published on: October 17, 2009
Reduced number of CD1a+ cells in cutaneous B-cell lymphoma
M Schmuth1, A Sidoroff, B Danner
1Dept of Dermatology, University of Innsbruck, Anichstr. 35, A-6020 Innsbruck, Austria.
Insights
Distinguishing cutaneous B-cell lymphoma from pseudolymphoma can be challenging. This study reveals that abundant CD1a+ dendritic cells are rare in B-cell lymphoma but common in pseudolymphoma, aiding differential diagnosis.
Area of Science:
- Dermatopathology
- Immunohistochemistry
- Oncology
Background:
- Cutaneous B-cell lymphoma (B-CL) and pseudolymphoma share overlapping clinical and histological features, complicating diagnosis.
- Current diagnostic criteria rely on histology and molecular analysis for monoclonal restriction.
- CD1a+ dendritic cells are known T-cell lymphoma markers, but their role in differentiating B-CL from pseudolymphoma is unexplored.
Purpose of the Study:
- To investigate the presence and diagnostic utility of CD1a+ dendritic cells in distinguishing B-cell lymphoma from pseudolymphoma.
- To compare the frequency of CD1a+ cells in B-cell lymphoma, pseudolymphoma, and T-cell lymphoma infiltrates.
Main Methods:
- Immunohistochemical analysis of frozen tissue sections.
- Studied 23 B-cell lymphomas, 13 pseudolymphomas, and 17 T-cell lymphomas.
- Quantified the presence and intensity of CD1a+ dendritic cell staining.
Main Results:
- Abundant CD1a+ dendritic cells were found in only 1 (4%) of B-cell lymphoma cases.
- Strong CD1a+ staining was present in 8 (62%) of pseudolymphoma cases.
- All 17 (100%) T-cell lymphoma cases showed strong CD1a+ staining.
Conclusions:
- A distinct pattern of CD1a+ dendritic cell infiltration differentiates B-cell lymphoma from pseudolymphoma.
- CD1a+ cell assessment offers a valuable adjunct in the differential diagnosis of these cutaneous disorders.
- This finding enhances diagnostic accuracy for challenging skin lesions.
Abstract:
Cutaneous B-cell lymphoma is difficult to distinguish from pseudolymphoma. The histologic pattern and monoclonal restriction (immunohistochemical analysis and molecular biology) are the criteria used for differentiating these entities. CD1a+ dendritic cells have been observed in the infiltrates of T-cell lymphoma, but the presence of these CD1a+ cells has not been compared in B-cell lymphoma and pseudolymphoma. We studied the presence of CD1a+ cells on frozen sections of 23 B-cell lymphomas, 13 pseudolymphomas, and 17 T-cell lymphomas by immunohistochemical analysis. We found abundant CD1a+ dendritic cells in only 1 (4%) of 23 B-cell lymphomas, whereas in 8 (62%) of 13 pseudolymphomas and 17 (100%) of 17 T-cell lymphomas, strong CD1a staining was present. Our study demonstrates a distinct pattern of CD1a staining in the infiltrates of B-cell lymphoma and pseudolymphoma that may be of value in the differential diagnosis of these skin disorders.
